Stock Events

Stock Events

Galectin Therapeutics (GALT) Q3 2024 Earnings

13AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-0.24

-0.21

-0.18

-0.15

Details

Expected EPS

-0.16

Actual EPS

-0.2

Surprise EPS

-0.04

Surprise Percent

+25%

Description

Galectin Therapeutics (GALT) has reported earnings of -0.2 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.